Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Korro Bio (KRRO) over the last 6 years, with Q3 2025 value amounting to 1653.58%.

  • Korro Bio's EBITDA Margin changed N/A to 1653.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 1204.41%, marking a year-over-year change of. This contributed to the annual value of 3668.56% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Korro Bio reported EBITDA Margin of 1653.58% as of Q3 2025.
  • In the past 5 years, Korro Bio's EBITDA Margin registered a high of 7072.54% during Q1 2023, and its lowest value of 1771.03% during Q2 2025.
  • Over the past 4 years, Korro Bio's median EBITDA Margin value was 917.29% (recorded in 2025), while the average stood at 166.25%.
  • Within the past 5 years, the most significant YoY rise in Korro Bio's EBITDA Margin was -1129100bps (2021), while the steepest drop was -3564400bps (2021).
  • Korro Bio's EBITDA Margin (Quarter) stood at 185.65% in 2021, then skyrocketed by 3910bps to 7072.54% in 2023, then plummeted by -113bps to 946.94% in 2024, then crashed by -75bps to 1653.58% in 2025.
  • Its last three reported values are 1653.58% in Q3 2025, 1771.03% for Q2 2025, and 917.29% during Q1 2025.